The Role of SGLT 2 Inhibitor in the Therapy of Obesity

Giovanno Sebastian, Yogie and Darren, Gosal and Yohanes, Firmansyah and Alexander Halim, Santoso (2023) The Role of SGLT 2 Inhibitor in the Therapy of Obesity. Asian Journal of Research and Reports in Endocrinology, 6 (1). pp. 104-114.

[thumbnail of Yogie612023AJRRE101565.pdf] Text
Yogie612023AJRRE101565.pdf - Published Version

Download (395kB)

Abstract

Obesity is an abnormal or excessive fat accumulation that presents a risk to health, including hypertension, stroke, kidney disease, atherosclerosis, type 2 diabetes mellitus, heart disease, and sleep apnea. Obesity can be caused by various aetiology, such as genetics, lifestyle, psychology, treatment, and more. Treatment of obesity is needed to prevent these further complications. According to various studies, SGLT 2 inhibitor has shown effectiveness in losing weight. This review article aims to describe the effectiveness and safety of SGLT 2 inhibitors in the treatment of obesity. It is expected SGLT 2 inhibitor can be considered in the administration of therapy in patients with obesity.

Item Type: Article
Subjects: Article Archives > Medical Science
Depositing User: Unnamed user with email support@articlearchives.org
Date Deposited: 12 Jul 2023 12:20
Last Modified: 27 Feb 2024 04:46
URI: http://archive.paparesearch.co.in/id/eprint/1861

Actions (login required)

View Item
View Item